If you made any changes in Pure these will be visible here soon.

Personal profile

Area of academic expertise - outline

I am an immunologist interested in the cellular and molecular pathways which drive inflammation within the arthritic joint. Much of my expertise lies in synovial biology and understanding the immune cell mechanisms (both innate and adaptive) which drive synovitis in rheumatoid arthritis (RA) and more recently in osteoarthritis (OA). I am also interested in the synovial fibroblast and its role in the development and perpetuation of both inflammation and tissue remodelling during arthritic joint disease.

Through my research activity I have developed expertise in a range of techniques, including induction and monitoring of in vivo models of arthritis. In addition to this I have expertise in a variety of in vitro techniques, including  cell culture (primary and cell lines), isolation and characterisation of immune cell populations (from buffy coats, spleen and bone marrow) and polarisation assays (macrophage subsets, Th17 and T regulatory (Treg) cells), explant culture (including synovial tissue and cartilage), isolation of synovial fibroblasts, generation of primary osteoclast cultures (murine and human), immunohistochemistry, multi-colour flow cytometry and western blot. I also have experience in ELISA and multiplex technology. 

Current research activities

The primary aim of my work is identification of novel molecular targets which hold therapeutic promise for future drug discovery programmes.  My research activity is aligned with the Centre for Musculoskeletal Science (CMS) within the Institute of Biomedical and Environmental Health Research (IBEHR), University of the West of Scotland (UWS). My current work is focused around proteinase activated receptor 2 (PAR2) which has been shown to be a critical molecular checkpoint in inflammatory joint disease and cartilage homeostasis. I am specifically interested in the mechanisms by which PAR2 drives the pathological changes associated with arthritis. This includes projects looking at the role of PAR2 in innate and adaptive immune responses. PAR2 is known to have a fundamental role in innate immunity where it can acts as a protease sensor, allowing cells such as macrophages, to respond quickly to changes in their microenvironment. I am interested in the role of PAR2 in macrophage subset development and effector function, including response to toll like receptor (TLR) challenge and how this fits within the context of joint pathology.

In a project funded by a Carnegie Research Incentive Grant,  I am looking at PAR2 regulation of T regulatory (Treg) cell development and function in an effort to underpin the mechanism by which this receptor regulates interleukin 17 (IL-17) in inflammatory arthritis. I am also interested in understanding how PAR2 regulated pathways in osteoarthritis synovial tissue impact on cartilage integrity within the diseased joint.

Desired research direction

My future research will be centred on understanding the mechanisms by which PAR2 regulates pathology within the arthritic joint. Elucidation of molecular pathways up and down stream of PAR2 will be critical in the development of novel therapies focused around this target. This work will be taken forward as part of a recently funded University of the West of Scotland PhD studentship (to commence in October 2016), looking at the secretome of OA synovial membrane, using an ‘omics’ approach to interrogate PAR2 relevant pathways. In addition to the work focused around PAR2, I am interested in identifying other cellular pathways which may hold therapeutic promise for the treatment of OA.  This includes taking forward a project recently funded by a Carnegie Collaborative Research Grant (due to commence in October 2016). The project will investigate the impact of novel IKKa inhibitors (developed at the University of Strathclyde) on osteoclast biology. This is an exciting new collaborative project with Dr Andrew Paul at the University of Strathclyde and Dr Carl Good Year, University of Glasgow and is an opportunity to add breadth to on-going research activity. 

Target collaborative organisations

With future research activity and elucidation of the cellular mechanisms which underpin OA joint pathology, it is hoped that there will be opportunities to foster industrial partnerships. I am keen to build on current external collaborations and to develop new partnerships with multidisciplinary teams to address the challenging research questions within the field of arthritis.     

Fingerprint Dive into the research topics where Anne Crilly is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Characterisation of exosomes isolated by ultracentrifugation from human primary bronchial epithelial cells

Downey, N., McGarvey, L., Martin, S. L., Crilly, A. & Lundy, F. T., 3 Feb 2020, In : Lung. 198, 1, p. 36-36 1 p.

Research output: Contribution to journalMeeting Abstract

  • Exosomes in intercellular communication and implications for osteoarthritis

    Asghar, S., Litherland, G. J., Lockhart, J. C., Goodyear, C. S. & Crilly, A., 1 Jan 2020, In : Rheumatology. 59, 1, p. 57-68 12 p.

    Research output: Contribution to journalReview article

  • 3 Citations (Scopus)

    Differential effects of exosomes derived from separate osteoarthritis synovial compartments: implications for erosive cartilage disease

    Asghar, S., Litherland, G., Meek, D., Cole, J., Lockhart, J., Goodyear, C. S. & Crilly, A., 30 Apr 2019, In : Osteoarthritis and Cartilage. 27, S1, p. S192 1 p., 260.

    Research output: Contribution to journalMeeting Abstract

  • 1 Citation (Scopus)

    Enhanced airway smooth muscle relaxation via proteinase activated receptor 2

    Black, K., MacKenzie, A., Dunning, L., Crilly, A., Brzeszczynska, J., McGarvey, L., Thornbury, K., Goodyear, C. S., Lockhart, J. C. & Litherland, G. J., 22 Nov 2019, In : Irish Journal of Medical Science. 188, SUPPL 10, p. 286-286 1 p.

    Research output: Contribution to journalMeeting Abstract

    Healthy primary epithelial cells show an elevated inflammatory response to bacterial stimulus compared to COPD cells

    Carson, S. A., Reihill, J. A., Fulton, C. R., McGarvey, L. P., Lundy, F. T., Crilly, A. & Thornbury, K. D., 1 Apr 2019, In : The FASEB Journal. 33, Supplement 1, 127.7.

    Research output: Contribution to journalMeeting Abstract

  • Prizes

    Asthma/COPD Project of the Year, 19th Northern Ireland Healthcare Awards 2018

    Lorraine Martin (Recipient), Lorcan McGarvey (Recipient), Fionnuala Lundy (Recipient), Litherland, Gary (Recipient), Lockhart, John (Recipient), Crilly, Anne (Recipient), Carl Goodyear (Recipient), Keith Thornbury (Recipient), Mark Hollywood (Recipient), Gerard Sergeant (Recipient) & Noel McHale (Recipient), 22 Feb 2018

    Prize: National/international honour

    Activities

    PhD Internal Examiner, Health and Life Sciences

    Anne Crilly (Examiner)

    6 Mar 2020

    Activity: Examination

    Medical Research Council (MRC) Reviewer

    Anne Crilly (Examiner)

    13 Apr 2020

    Activity: OtherTypes of External academic engagement - Contribution to the work of national or international committees and working groups

    GSK Site Visit

    John Lockhart (Organiser), , Mark Thomas (Participant), , Kimberly Black (Participant), , Kirsty McCallum (Participant), , Sabha Asghar (Participant), , Fawziye Tarhini (Participant), , Mari Bailo (Participant), , Gary Litherland (Organiser), , Anne Crilly (Organiser), , Carly Woods (Participant), & Bryn Short (Participant)

    14 Mar 201915 Mar 2019

    Activity: Participating in or organising an eventParticipation in workshop, seminar, course

    Meeting with TEVA UK

    Anne Crilly (Organiser), , Gary Litherland (Participant), & John Lockhart (Participant)

    15 Nov 2019

    Activity: Other

    Press / Media

    Profiles